Attitudes towards open-label versus placebo-control designs in oncology randomized trials: A survey of medical oncologists.

Rationale, Aims And Objectives: Randomized trials are considered the gold standard when assessing the efficacy of new therapeutic agents. In clinical situations where no standard of care therapy is approved, randomized trials usually compare experimental agents to either a placebo or an open-label nonintervention arm (i.e.